295 related articles for article (PubMed ID: 19684511)
61. [Blastic plasmacytoid dendritic cell neoplasm: report of a case].
Zhang H; Liang ZY
Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):710-1. PubMed ID: 22321557
[No Abstract] [Full Text] [Related]
62. Extensive flow cytometric characterization of plasmacytoid dendritic cell leukemia cells.
Gopcsa L; Banyai A; Jakab K; Kormos L; Tamaska J; Matolcsy A; Gogolak P; Rajnavolgyi E; Paloczi K
Eur J Haematol; 2005 Oct; 75(4):346-51. PubMed ID: 16146542
[TBL] [Abstract][Full Text] [Related]
63. Applying the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome in primary cutaneous marginal zone lymphoma.
Gerami P; Wickless SC; Rosen S; Kuzel TM; Ciurea A; Havey J; Guitart J
J Am Acad Dermatol; 2008 Aug; 59(2):245-54. PubMed ID: 18486274
[TBL] [Abstract][Full Text] [Related]
64. Hyperplasia of hair follicles and other adnexal structures in cutaneous lymphoproliferative disorders: a study of 53 cases, including so-called pseudolymphomatous folliculitis and overt lymphomas.
Kazakov DV; Belousova IE; Kacerovska D; Sima R; Vanecek T; Vazmitel M; Pizinger K; Michal M
Am J Surg Pathol; 2008 Oct; 32(10):1468-78. PubMed ID: 18685486
[TBL] [Abstract][Full Text] [Related]
65. Rimming of adipocytes by neoplastic lymphocytes: a histopathologic feature not restricted to subcutaneous T-cell lymphoma.
Lozzi GP; Massone C; Citarella L; Kerl H; Cerroni L
Am J Dermatopathol; 2006 Feb; 28(1):9-12. PubMed ID: 16456318
[TBL] [Abstract][Full Text] [Related]
66. Blastic plasmacytoid dendritic cell neoplasm.
Munoz J; Rana J; Inamdar K; Nathanson D; Janakiraman N
Am J Hematol; 2012 Jul; 87(7):710. PubMed ID: 21953644
[No Abstract] [Full Text] [Related]
67. Blastic plasmacytoid dendritic cell neoplasm with acute myeloid leukemia successfully treated to a remission currently of 26 months duration.
Voelkl A; Flaig M; Roehnisch T; Alpay N; Schmidmaier R; Oduncu F
Leuk Res; 2011 Jun; 35(6):e61-3. PubMed ID: 21167600
[No Abstract] [Full Text] [Related]
68. Cutaneous indeterminate dendritic cell tumor with a protracted relapsing clinical course.
Cheuk W; Cheung FY; Lee KC; Chan JK
Am J Surg Pathol; 2009 Aug; 33(8):1261-3. PubMed ID: 19471157
[No Abstract] [Full Text] [Related]
69. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
Edelson RL
Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
[TBL] [Abstract][Full Text] [Related]
70. A woman with rare blastic plasmacytoid dendritic cell neoplasm on the face.
Huang YY; Liu YR; Li K; Li K; Liu SH
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Jan; 121(1):e16-8. PubMed ID: 26159087
[TBL] [Abstract][Full Text] [Related]
71. Plasmacytoid dendritic cell neoplasm treated successfully with rituximab.
Kedward AL; McGalie C; Venkatraman L; Hamilton J; El-Agnaf M; McKenna K
J Eur Acad Dermatol Venereol; 2010 Jun; 24(6):742-3. PubMed ID: 20565563
[No Abstract] [Full Text] [Related]
72. Blastic plasmacytoid dendritic cell neoplasm in a human T-cell lymphotropic virus type I (HTLV-1) carrier: a coincidental association?
Uchida Y; Kawai K; Kubo H; Takeda K; Shimokawa M; Yoshii N; Kanekura T
Eur J Dermatol; 2013 Apr; 23(2):250-1. PubMed ID: 23558032
[No Abstract] [Full Text] [Related]
73. Blastic plasmacytoid dendritic cell neoplasm.
Lencastre A; Cabete J; João A; Farinha P; Ferreira G; Lestre S
An Bras Dermatol; 2013; 88(6 Suppl 1):158-61. PubMed ID: 24346907
[TBL] [Abstract][Full Text] [Related]
74. L-asparaginase with methotrexate and dexamethasone is an effective treatment combination in blastic plasmacytoid dendritic cell neoplasm.
Gruson B; Vaida I; Merlusca L; Charbonnier A; Parcelier A; Damaj G; Royer B; Marolleau JP
Br J Haematol; 2013 Nov; 163(4):543-5. PubMed ID: 23937331
[No Abstract] [Full Text] [Related]
75. Cytomorphological features of blastic plasmacytoid dendritic cell neoplasm on FNA and cerebrospinal fluid cytology: A review of 6 cases.
Ferreira J; Gasparinho MG; Fonseca R
Cancer Cytopathol; 2016 Mar; 124(3):196-202. PubMed ID: 26618304
[TBL] [Abstract][Full Text] [Related]
76. Immunohistochemical analysis of CD123, CD56 and CD4 for the diagnosis of minimal bone marrow involvement by blastic plasmacytoid dendritic cell neoplasm.
Hwang K; Park CJ; Jang S; Chi HS; Huh JR; Lee JH; Suh C; Lee KH
Histopathology; 2013 Apr; 62(5):764-70. PubMed ID: 23470050
[TBL] [Abstract][Full Text] [Related]
77. A rare case of blastic plasmacytoid dendritic cell neoplasm with deletion 7q.31, in the setting of heavy pre-treatment with alkylating chemotherapy.
Kaur V; Swami A; Shebli A; Shalin S; Veeraputhiran M; Emanuel P; Jethava Y
J Oncol Pharm Pract; 2017 Oct; 23(7):552-556. PubMed ID: 27559020
[TBL] [Abstract][Full Text] [Related]
78. [Rare diagnosis of CD4+56+ leukemia from dendritic cells type DC2].
Klabusay M; Pevná M; Kissová J; Doubek M; Heidekerová M; Mayer J; Vorlícek J
Cas Lek Cesk; 2008; 147(10):511-5. PubMed ID: 19177732
[TBL] [Abstract][Full Text] [Related]
79. Occurrence of Hodgkin's disease and cutaneous B-cell lymphoma in the same patient: a report of two cases.
Servitje O; Martí RM; Estrach T; Palou J; Gallardo F; Limón A; Romagosa V
Eur J Dermatol; 2000; 10(1):43-6. PubMed ID: 10694298
[TBL] [Abstract][Full Text] [Related]
80. Blastic plasmacytoid dendritic cell neoplasms: clinico-immunohistochemical correlations in a series of 91 patients.
Julia F; Dalle S; Duru G; Balme B; Vergier B; Ortonne N; Vignon-Pennamen MD; Costes-Martineau V; Lamant L; Dalac S; Delattre C; Déchelotte P; Courville P; Carlotti A; De Muret A; Fraitag S; Levy A; Mitchell A; Petrella T
Am J Surg Pathol; 2014 May; 38(5):673-80. PubMed ID: 24441662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
